Allyson Mullen

Allyson B. Mullen is a Director at Hyman, Phelps & McNamara, P.C., a law firm specializing in FDA regulatory matters.12 She is an experienced attorney who focuses on assisting clients with a wide range of pre- and postmarket regulatory topics in the medical device industry.2

Professional Background

Mullen's expertise includes:

• Developing regulatory strategies
• Preparing regulatory submissions
• Advising on FDA compliance issues

She has been with Hyman, Phelps & McNamara, P.C. for several years, having joined the firm in June 2019 and becoming a Director in January 2019.5

Recent Appointments

Recently, Allyson B. Mullen was appointed to the Board of Directors of the Association of Medical Diagnostic Manufacturers (AMDM) for the 2024-2026 term.3 This appointment highlights her standing in the medical device regulatory field and her contributions to the industry.

Professional Network

Mullen maintains an active presence on LinkedIn, where she has over 500 connections.4 Her LinkedIn profile can be found under the username allyson-mullen-99a5b33, as mentioned in the query.

Areas of Practice

While primarily focused on FDA regulatory matters, particularly in the medical device sector, it's worth noting that Mullen's expertise has also been recognized in construction law.6 This suggests a diverse legal background, though her primary focus appears to be on FDA-related issues.

Allyson B. Mullen's role as a Director at Hyman, Phelps & McNamara, P.C. and her various appointments and recognitions indicate that she is a respected professional in the field of FDA regulatory law, particularly in matters related to medical devices and diagnostics.